Contents: Fluorescein isothiocyanate (FITC) anti-human CD22
Catalog Number: 11-0229
Formulation: Phosphate buffered saline, pH 7.2, less than or equal to 0.09% NaN3, BSA and/or gelatin for protein stabilization
Storage Conditions: Store at 4°C.
DO NOT FREEZE.
LIGHT-SENSITIVE MATERIAL.
Clone: eBio4KB128 (4KB128)
Isotype: Mouse IgG1, κ
| Prices for This Product* |
| Cat. No. |
Size |
Price |
Qty |
Action |
*International customers: Please contact your distributor for region specific pricing.
|
|
 
Staining of normal human peripheral blood cells with APC anti-human CD19 (HIB19) (cat. 17-0199) and 0.25 μg of FITC Mouse IgG1, K Iso Cntrl (cat. 11-4714) (left) or FITC anti-human CD22 (4KB128) (right). Cells in the lymphocyte gate were used for analysis.
|
Questions? Please consult our answers to frequently asked questions at
http://www.ebioscience.com/faq.
Description
The eBio4KB128 monoclonal antibody recognizes human CD22 (Siglec-2), which is a member of the siglec subgroup of the Ig superfamily. CD22 is a type I transmembrane glycoprotein composed of two polypeptide chains, CD22α and CD22β, of 130 and 140 kDa respectively, produced by alternative splicing of the CD22 gene. CD22 is expressed at high levels on mature B cells and B cell lymphomas. The extracellular portion of CD22 contains seven Ig-like domains, some of which are capable of binding ligands with sialic acid moieties expressed on epithelial, endothelial, B and T cells. The intracellular portion of CD22 contains 6 tyrosine residues contained within immunotyrosine-based inhibitory motifs (ITIM) and immunotyrosine-based activation-like motifs, which are phosphorylated upon B-cell receptor engagement, which enables CD22 to participate in the positive and negative regulation of B-cell receptor signaling.
Applications Reported
For research use only, not for diagnostic or therapeutic use. This eBio4KB128 (4KB128) antibody has been reported for use in flow cytometric analysis.
Applications Tested
This eBio4KB128 (4KB128) antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells. This can be used at 20 μl (0.25 μg) per 100 μl blood (or per 1 million cells in 100 μl total staining volume).
References
Mason DY, Stein H, Gerdes J, Pulford KA, Ralfkiaer E, Falini B, Erber WN, Micklem K, Gatter KC.
Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells.
Blood. 1987 Mar;69(3):836-40. (
4KB128, IHC,
PubMed)
Campana D, Janossy G, Bofill M, Trejdosiewicz LK, Ma D, Hoffbrand AV, Mason DY, Lebacq AM, Forster HK.
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
J Immunol. 1985 Mar;134(3):1524-30.
Nitschke L.
The role of CD22 and other inhibitory co-receptors in B-cell activation.
Curr Opin Immunol. 2005 Jun;17(3):290-7. Review.
Related Products
Cat.
11-0221 Fluorescein isothiocyanate (FITC) anti-mouse CD22 (clone 2D6)
Cat.
11-4714 Fluorescein isothiocyanate (FITC) Mouse IgG1, K Isotype Control
Human Cellular Antigens Chart